A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia

Conclusions. GE was safe and did not reduce FN risk in the entire cohort, but yet appeared to exert a protective effect in the lower-risk subgroup. We do not recommend the use of GE for FN prevention in higher-risk patients. A larger-scale clinical trial for the lower-risk subgroup of patients is advocated. (This trial was registered at www.clinicaltrials.gov as NCT00247039.)

Source: Integrative Cancer Therapies - August 14, 2015 Category: Cancer & Oncology Authors: Gatt, M. E., Strahilevitz, J., Sharon, N., Lavie, D., Goldschmidt, N., Kalish, Y., Gural, A., Paltiel, O. B. Tags: Articles Source Type: research